Mayo Clinic Researcher to Present Findings on Aditxt's ADI-100™ Preclinical Study
Aditxt Inc. will host a May 2 update featuring Mayo Clinic's Dr. Charles Howe discussing key findings from a preclinical study of ADI-100™, offering insights into the company's immune modulation therapy research.
